Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
British Society of Gastroenterology guidelines for diagnosis and management of autoimmune hepatitis.
Gleeson D, Bornand R, Brownlee A, Dhaliwal H, Dyson JK, Hails J, Henderson P, Kelly D, Mells GF, Miquel R, Oo YH, Sutton A, Yeoman A, Heneghan MA.
Gut. 2025 Aug 7;74(9):1364-1409. doi: 10.1136/gutjnl-2024-333171.
Hepatotoxicity.
Zimmerman HJ.
Dis Mon. 1993 Oct;39(10):675-787.
Drug-induced hepatotoxicity.
Kaplowitz N, Aw TY, Simon FR, Stolz A.
Ann Intern Med. 1986 Jun;104(6):826-39. doi: 10.7326/0003-4819-104-6-826.
The Liver in Oncology.
Dhanasekaran R, Kwo PY.
Clin Liver Dis. 2017 Nov;21(4):697-707. doi: 10.1016/j.cld.2017.06.003. Epub 2017 Jul 26.
Chronic Kidney Disease--Chronic Liver Disease. An Immunologic Cross-talk.
Gluhovschi G, Petrică L, Sporea I, Timar R, Curescu M, Velciov S, Gluhovschi C.
Rom J Intern Med. 2015 Jan-Mar;53(1):3-12. doi: 10.1515/rjim-2015-0001.
Inherited hepatocellular carcinoma.
Villanueva A, Newell P, Hoshida Y.
Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):725-34. doi: 10.1016/j.bpg.2010.07.008.
Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease.
Danielsson O, Vesterinen T, Arola J, Åberg F, Nissinen MJ.
Eur J Gastroenterol Hepatol. 2024 Jul 1;36(7):961-969. doi: 10.1097/MEG.0000000000002785. Epub 2024 Apr 26.
Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics.
Gatselis NK, Zachou K, Koukoulis GK, Dalekos GN.
World J Gastroenterol. 2015 Jan 7;21(1):60-83. doi: 10.3748/wjg.v21.i1.60.
Alpha-kinase 1 (ALPK1) agonist DF-006 demonstrates potent efficacy in mouse and primary human hepatocyte (PHH) models of hepatitis B.
Xu C, Fan J, Liu D, Tuerdi A, Chen J, Wei Y, Pan Y, Dang H, Wei X, Yousif AS, Yogaratnam J, Zhou Q, Lichenstein H, Xu T.
Hepatology. 2023 Jan 1;77(1):275-289. doi: 10.1002/hep.32614. Epub 2022 Sep 17.
Tendon Disorders in Chronic Liver Disease: A Retrospective Cohort Study in Taiwan.
Lin CY, Huang SC, Tzou SJ, Yin CH, Chen JS, Chen YS, Chang ST.
Int J Environ Res Public Health. 2023 Mar 12;20(6):4983. doi: 10.3390/ijerph20064983.
